Swiss National Bank

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$989,804	64,273	+1,100	+1.7%	$15.40	Q4 2025
30 Sep 2025	0%	+0%	$1,293,151	63,173	+1,300	+2.1%	$20.47	Q3 2025
30 Jun 2025	0%	+0%	$1,241,172	61,873	+20,000	+48%	$20.06	Q2 2025
31 Mar 2025	0%	0%	$824,061	41,873	0		$19.68	Q1 2025
31 Dec 2024	0%	+0%	$942,143	41,873	+5,100	+14%	$22.50	Q4 2024
30 Sep 2024	0%	0%	$939,182	36,773	0		$25.54	Q3 2024
30 Jun 2024	0%	0%	$859,385	36,773	0		$23.37	Q2 2024
31 Mar 2024	0%	+0%	$646,837	36,773	+300	+0.82%	$17.59	Q1 2024
31 Dec 2023	0%	-0%	$504,786	36,473	-4,200	-10%	$13.84	Q4 2023
30 Sep 2023	0%	-0%	$555,593	40,673	-8,500	-17%	$13.66	Q3 2023
30 Jun 2023	0%	+0%	$1,003,621	49,173	+49,173	NEW	$20.41	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.